Hilltop Holdings’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
Other funds holding KYNB
HA
Hilltop Holdings's KYNB Position: Q1 2021 in Review
Hilltop Holdings sold out of Kyntra Bio (KYNB) in Q1 2021, closing a stake of 1,428 shares — an estimated $1.32M sold.
Hilltop Holdings first reported a position in KYNB in Q1 2015 and held it in 24 quarters. The position peaked at $3.45M in Q2 2018. 198 funds tracked by Wall St. Rank hold KYNB as of Q1 2021.
- Hilltop Holdings reported no remaining Kyntra Bio position as of Q1 2021 after selling out during the quarter.
- Hilltop Holdings sold 1,428 Kyntra Bio shares in Q1 2021, an estimated $1.32M.
- Hilltop Holdings first reported a position in Kyntra Bio in Q1 2015 and held it in 24 quarters.
- Hilltop Holdings's Kyntra Bio position peaked at $3.45M in Q2 2018.
- 198 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2021.
Based on Hilltop Holdings's 13F filing for Q1 2021, filed 17 May 2021.